Specifically, the TGF-β co-receptor endoglin (CD105) and the Hedgehog mediator Gli 1/2, which are overexpressed in recurrent ovarian cancers, both affect the viability of ovarian cancer cells, and Gli 2 also affects resistance to cisplatin. Here, ENG is linked to ovarian carcinoma.